|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.090 USD | -1.80% |
|
+3.81% | -69.12% |
| 06-08 | ADC Therapeutics Shares Fall After HC Wainwright Downgrade | MT |
| 06-08 | HC Wainwright Downgrades ADC Therapeutics to Neutral From Buy | MT |
| Market Cap | 139M 121M 112M 105M 197M 13.08B 198M 1.33B 515M 6.44B 520M 509M 22.36B | P/E 2026 * |
-1.28x | P/E 2027 * | -1.65x |
|---|---|---|---|---|---|
| Enterprise Value | 139M 121M 112M 105M 197M 13.08B 198M 1.33B 515M 6.44B 520M 509M 22.36B | EV / Sales 2026 * |
1.7x | EV / Sales 2027 * | 1.12x |
| Free-Float |
84.85% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: ADC Therapeutics SA
| 1 day | -1.80% | ||
| 1 week | +3.81% | ||
| Current month | -67.94% | ||
| 1 month | -65.29% | ||
| 3 months | -73.02% | ||
| 6 months | -70.78% | ||
| Current year | -69.12% |
| 1 week | 0.98 |  | 1.13 |
| 1 month | 0.78 | | 3.7 |
| Current year | 0.78 | | 4.98 |
| 1 year | 0.78 | | 4.98 |
| 3 years | 0.36 | | 6.04 |
| 5 years | 0.36 | | 32 |
| 10 years | 0.36 | | 56.59 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ameet Mallik
CEO | Chief Executive Officer | 53 | 09/05/2022 |
Jose Carmona
DFI | Director of Finance/CFO | 53 | 19/12/2022 |
David Ege
CTO | Chief Tech/Sci/R&D Officer | 52 | 01/10/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Peter Hug
BRD | Director/Board Member | 67 | 01/06/2019 |
Tyrell J. Rivers
BRD | Director/Board Member | 53 | 01/06/2018 |
Ron Squarer
CHM | Chairman | 59 | 01/03/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-03 | Tax | Chairman | -15,196 | 0.0119% | ||
| 06-03 | Tax | Director | -12,600 | 0.0099% | ||
| 06-03 | Tax | Director | -12,600 | 0.0099% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.80% | +3.81% | -64.03% | -52.40% | 139M | |
| +1.44% | -1.25% | +63.52% | +114.88% | 55.19B | |
| +4.60% | +3.02% | +58.20% | +47.16% | 45.75B | |
| -1.44% | +0.39% | -12.94% | -19.24% | 22.98B | |
| -2.69% | -2.10% | -3.68% | +379.00% | 20.76B | |
| +3.22% | -0.84% | +27.88% | -34.00% | 16.26B | |
| +0.58% | +1.08% | +16.73% | -38.06% | 15.42B | |
| -1.01% | -2.30% | +27.42% | +171.92% | 13.05B | |
| +4.95% | +11.70% | +123.63% | +252.19% | 12.45B | |
| +3.07% | +0.14% | +29.37% | - | 12.37B | |
| Average | +1.09% | +2.29% | +26.61% | +91.27% | 21.44B | |
| Weighted average by Cap. | +1.63% | +1.48% | +40.85% | +99.81% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 81.46M 71.03M 65.78M 61.58M 115M 7.69B 116M 780M 302M 3.78B 306M 299M 13.14B | 124M 108M 100M 93.77M 176M 11.7B 177M 1.19B 461M 5.76B 466M 456M 20B |
| Net income | -136M -118M -110M -103M -192M -12.8B -194M -1.3B -504M -6.3B -509M -498M -21.88B | -117M -102M -94.82M -88.76M -166M -11.08B -167M -1.12B -436M -5.45B -441M -431M -18.94B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/06/26 | 1.090 $ | -1.80% | 1,725,034 |
| 17/06/26 | 1.110 $ | +11.41% | 2,078,345 |
| 16/06/26 | 0.9963 $ | -5.11% | 1,284,089 |
| 15/06/26 | 1.050 $ | 0.00% | 1,851,125 |
| 12/06/26 | 1.050 $ | -0.94% | 1,552,071 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ADCT Stock
Select your edition
All financial news and data tailored to specific country editions
